- Home
- ICCT vs SONN Comparison
ICCT vs SONN Comparison
Compare ICCT & SONN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICCT
- SONN
- Stock Information
- Founded
- ICCT 1992
- SONN N/A
- Country
- ICCT United States
- SONN United States
- Employees
- ICCT N/A
- SONN N/A
- Industry
- ICCT Computer Software: Prepackaged Software
- SONN Biotechnology: Pharmaceutical Preparations
- Sector
- ICCT Technology
- SONN Health Care
- Exchange
- ICCT Nasdaq
- SONN Nasdaq
- Market Cap
- ICCT 2.9M
- SONN 2.5M
- IPO Year
- ICCT N/A
- SONN N/A
- Fundamental
- Price
- ICCT $2.05
- SONN $1.44
- Analyst Decision
- ICCT
- SONN Strong Buy
- Analyst Count
- ICCT 0
- SONN 2
- Target Price
- ICCT N/A
- SONN $38.00
- AVG Volume (30 Days)
- ICCT 339.7K
- SONN 98.6K
- Earning Date
- ICCT 11-19-2024
- SONN 02-13-2025
- Dividend Yield
- ICCT N/A
- SONN N/A
- EPS Growth
- ICCT N/A
- SONN N/A
- EPS
- ICCT N/A
- SONN N/A
- Revenue
- ICCT $11,049,477.00
- SONN $1,000,000.00
- Revenue This Year
- ICCT N/A
- SONN N/A
- Revenue Next Year
- ICCT N/A
- SONN N/A
- P/E Ratio
- ICCT N/A
- SONN N/A
- Revenue Growth
- ICCT 42.66
- SONN 674.14
- 52 Week Low
- ICCT $2.01
- SONN $1.38
- 52 Week High
- ICCT $35.80
- SONN $18.72
- Technical
- Relative Strength Index (RSI)
- ICCT 37.79
- SONN 37.03
- Support Level
- ICCT $2.01
- SONN $1.38
- Resistance Level
- ICCT $2.22
- SONN $1.60
- Average True Range (ATR)
- ICCT 0.13
- SONN 0.09
- MACD
- ICCT -0.00
- SONN -0.01
- Stochastic Oscillator
- ICCT 5.99
- SONN 19.35
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.